Market Place
Sourcing Support
PTC Therapeutics To Share PIVOT-HD Study Long-Term Results
28 Apr 2026 //
PR NEWSWIRE
Argo Biopharma Doses First Patient in BW-50218 Phase 1 Trial
28 Apr 2026 //
PR NEWSWIRE
Novartis Gets CHMP Nod For Itvisma In SMA
24 Apr 2026 //
GLOBENEWSWIRE
Biontech To Turn Out The Lights At Singapore Vaccine Facility
02 Apr 2026 //
FIERCE PHARMA
Novartis to buy based biotech firm Excellergy for up to $2 bn
27 Mar 2026 //
REUTERS
Novartis to Buy Experimental Breast Cancer Drug in up to $3B
23 Mar 2026 //
REUTERS
Novartis` Cosentyx Gets FDA Approval for Moderate-to-Severe HS
14 Mar 2026 //
GLOBENEWSWIRE
How Jeff Legos Builds Pfizer`s Oncology Future
04 Mar 2026 //
FIERCE BIOTECH
Novartis Completes Acquisition of Avidity Biosciences
27 Feb 2026 //
GLOBENEWSWIRE
Atrium Arises From Avidity Buyout With $270M, Preclinical Assets
27 Feb 2026 //
FIERCE BIOTECH
Novartis Picks Texas City for 5th U.S. Radiopharm Facility
25 Feb 2026 //
BIOSPACE
Novartis Reveals Rhapsido`s Broader Reach Beyond CSU at AAAAI
23 Feb 2026 //
GLOBENEWSWIRE
Novartis` Remibrutinib First to Meet Phase III Endpoint in CIndU
20 Feb 2026 //
GLOBENEWSWIRE
Novartis Finds Natural Partnership In Macrocycle Biotech
20 Feb 2026 //
FIERCE BIOTECH
Novartis Jettisons Ph. 1 Cancer Candidate After 0% Efficacy
19 Feb 2026 //
FIERCE BIOTECH
Novartis Vanrafia Shows Phase III Data Backing Kidney Function
13 Feb 2026 //
GLOBENEWSWIRE
Niowave, Novartis Ink Actinium-225 Deal for Cancer Therapy
11 Feb 2026 //
PR NEWSWIRE
Novartis Initiates Construction Of San Diego Biomedical Research
06 Feb 2026 //
GLOBENEWSWIRE
Novartis Cuts 6 Cancer Candidates, Adds 2 to Oncology Strategy
05 Feb 2026 //
BIOSPACE
Novartis Doesn`t Need GLP-1s in Me-Too World
13 Jan 2026 //
BIOSPACE
Zonsen Peplib Biotech And Novartis Ink Global License Deal
13 Jan 2026 //
PHARMIWEB
JPM26, Day 1: Updates From Lilly, Takeda, Novartis And Sofinnova
12 Jan 2026 //
FIERCE BIOTECH
Novartis Makes $1.5B+ Alzheimer`s Play With China`s Scineuro
12 Jan 2026 //
PR NEWSWIRE
Voyager Jettisons Staff, Novartis Hands Back 2 Programs
18 Dec 2025 //
FIERCE BIOTECH
Novartis Pens $1.7 B Immuno-Dermatology Pact with AI Biotech
10 Dec 2025 //
GLOBENEWSWIRE
Novartis` Kisqali Keeps 1 in 4 Patients Progression-Free
09 Dec 2025 //
GLOBENEWSWIRE
Novartis` Ianalumab Sustains ITP Control for 4 Months
09 Dec 2025 //
GLOBENEWSWIRE
Novartis-Backed Protego Secures $130M for Pivotal Amyloidosis
01 Dec 2025 //
BIOSPACE
Novartis Showcases Hematology and Oncology Data at ASH and SABCS
25 Nov 2025 //
GLOBENEWSWIRE
Novartis Opens Radioligand Therapy Facility In Carlsbad, US
15 Nov 2025 //
INDPHARMAPOST
Novartis` Resistance-Busting Malaria Drug Hits Phase 3 Goal
13 Nov 2025 //
FIERCE BIOTECH
Novartis Unveils Data On First Targeted Sjögren`s Treatment
29 Oct 2025 //
BIOSPACE
Novartis` Phase 3 Wins In Sjögren`s See High Placebo Effect
29 Oct 2025 //
FIERCE BIOTECH
Novartis Bolsters Neuromuscular Pipeline Via $12B Avidity Buyout
27 Oct 2025 //
BIOSPACE
Novartis` Cosentyx® Succeeds In Phase III Trial For PMR
22 Oct 2025 //
GLOBENEWSWIRE
Novartis` Pluvicto Slows Progression In Earlier Prostate Cancer
19 Oct 2025 //
FIERCE PHARMA
Novartis` Scemblix® Gets Positive CHMP Opinion For Newly CML
17 Oct 2025 //
GLOBENEWSWIRE
Novartis Kisqali Cuts Recurrence Risk by 28% in NATALEE Data
17 Oct 2025 //
GLOBENEWSWIRE
Novartis Launches Direct-To-Patient Platform For Cosentyx In US
29 Sep 2025 //
GLOBENEWSWIRE
Novartis Data Support Kesimpta In Relapsing MS After Oral Switch
24 Sep 2025 //
GLOBENEWSWIRE
NRG Secures £50M Series B Funding for Parkinson`s Research
08 Sep 2025 //
GLOBENEWSWIRE
Novartis Signs up To $5.2 B Deal with China`s Biotech Argo
04 Sep 2025 //
REUTERS
Arrowhead, Novartis in Up to $2B Deal for Neuromuscular Therapy
03 Sep 2025 //
REUTERS
Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier
29 Aug 2025 //
BIOSPACE
BioArctic: Interim Report for the period April - June 2025
28 Aug 2025 //
PR NEWSWIRE
Lilly Answers Novartis Breast Cancer Rivalry with Survival Win
27 Aug 2025 //
FIERCE PHARMA
Novartis pens BioArctic neuro pact worth $30M upfront
27 Aug 2025 //
FIERCE BIOTECH
Novartis, BioArctic Partner on BrainTransporter for Neurology
26 Aug 2025 //
EXPRESSPHARMA
Novartis Scores Double Phase 3 Win in Sjögren`s Syndrome
12 Aug 2025 //
FIERCE BIOTECH
Novartis Weighs Deal for Biotech Avidity Biosciences
09 Aug 2025 //
REUTERS
Novartis Hunts New Assets, Rumored Takeover of RNA Specialist
07 Aug 2025 //
BIOSPACE
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
26 Jul 2025 //
GLOBENEWSWIRE
Novartis inks $175M option deal for Sironax’s blood-brain barrier
10 Jul 2025 //
PR NEWSWIRE
Novartis Drug Cosentyx Fails Late-Stage Trial for Artery Disease
05 Jul 2025 //
REUTERS
Novartis Pens ProFound Pact for Cardiovascular Disease Targets
27 Jun 2025 //
FIERCE BIOTECH
Novartis completes acquisition of Regulus Therapeutics
25 Jun 2025 //
GLOBENEWSWIRE
Amneal, Kashiv Report Positive Data for Xolair Biosimilar
25 Jun 2025 //
GLOBENEWSWIRE
Erasca looks to partner off late-stage melanoma asset
14 May 2025 //
FIERCE BIOTECH
PTC and Novartis’ Huntington`s data fail to convince investors
07 May 2025 //
FIERCE BIOTECH
Novartis to buy Regulus in up to $1.7 Billion deal
01 May 2025 //
REUTERS
